Polymethacrylates as Polymeric Film Formation in Patches Containing α-Mangostin and Resveratrol

Article Preview

Abstract:

Polymethacrylates polymeric film formation in patches containing α-mangostin and resveratrol were developed using solvent casting method. Eudragit® E100 (E) and Eudragit® L100 (L) were dissolved in ethanol and the plasticizer (propylene glycol (PG) and polyethylene glycol (PEG) 400) was individual added and followed with the drying process. The dried films were evaluated for the morphology and flexibility. After the stable film was achieved, the α-mangostin and resveratrol were incorporated into the film. The variation of weight and thickness, swelling property, pH surface, mechanical properties and drug content of patches was evaluated. Fourier transform infrared spectrophotometry (FT-IR) was also conducted to confirm that drugs were qualitatively loaded into the patches. The results indicated that patch of L and PG was found to be stable. PG enhanced the flexibility of patch. The patches were less variation in weight and thickness. This patch did not effect to the physiological pH in the human body. In addition, patch had a tensile strength high enough to withstand tearing during handing. The qualitative and quantitative analysis indicated the α-mangostin and resveratrol was well incorporated in this patch. These results suggest that polymethacrylate polymer could be a promising polymeric film formation in patches for drug delivery.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

51-56

Citation:

Online since:

August 2019

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2019 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

* - Corresponding Author

[1] R.P. Dixit, S.P. Puthli, Oral strip technology: Overview and future potential, J Control Release,139 (2009) 94-107.

DOI: 10.1016/j.jconrel.2009.06.014

Google Scholar

[2] L.A. Felton, Mechanisms of polymeric film formation, Int J Pharm. 452 (2013) 423-427.

Google Scholar

[3] R.C. Rowe, P.J. Sheskey., M.E. Quinn, Handbook of Pharmaceutical Excipients, sixth ed., London, UK, (2009).

Google Scholar

[4] J. Pedraza-Chaverri, N. Cárdenas-Rodríguez, M. Orozco-Ibarra, J.M. Pérez-Rojas, Medicinal properties of mangosteen (Garcinia mangostana), Food Chem Toxicol. 46 (2008) 3227-3239.

DOI: 10.1016/j.fct.2008.07.024

Google Scholar

[5] L. Paulo, S. Ferreira, E. Gallardo, J.A. Queiroz, Antimicrobial activity and effects of resveratrol on human pathogenic bacteria, World J Microbiol Biotechnol. 26 (2010) 1533-1538.

DOI: 10.1007/s11274-010-0325-7

Google Scholar

[6] S. Ataei, R. Yahya, S.N. Gan, Coating performances of copolymers from a novel palm oil‐based macromer and methyl methacrylate, Pigm Resin Technol. 41 (2012) 112-121.

DOI: 10.1108/03699421211210775

Google Scholar

[7] S. Thakral, N.K Thakral, D.K, Majumdar, Eudragit®: a technology evaluation, Expert Opin. Drug Deliv. 10 (2013) 131-149.

DOI: 10.1517/17425247.2013.736962

Google Scholar

[8] V.M. Patel, B.G. Prajapati, M.M, Patel, Effect of hydrophilic polymers on buccoadhesive eudragit patches of propranolol hydrochloride using factorial design, AAPS PharmSciTech. 8 (2007) E119–E126.

DOI: 10.1208/pt0802045

Google Scholar

[9] L. Perioli, V. Ambrogi, F. Angelici, M. Ricci, S. Giovagnoli, M. Capuccella, C. Rossi, Development of mucoadhesive patches for buccal administration of ibuprofen, J Control Release. 99 (2004) 73-82.

DOI: 10.1016/j.jconrel.2004.06.005

Google Scholar

[10] S.A.I.S.M. Ghazali, G.E.C. Lian, K.D.A. Ghani, Chemical constituent from roots of Garcinia mangostana (Linn.), Int J Chem. 2 (2010) 2134-2142.

DOI: 10.5539/ijc.v2n1p134

Google Scholar

[11] V. Venuti, C.Cannavà, M.C. Cristiano, M. Fresta, D. Majolino, D. Paolino, R. Stancanelli, S. Tommasini, C.A. Ventura, A characterization study of resveratrol/sulfobutyl ether-β-cyclodextrin inclusion complex and in vitro anticancer activity, Colloid Surface B. 115 (2014) 22-28.

DOI: 10.1016/j.colsurfb.2013.11.025

Google Scholar